| Yip, S and Pavlakis, N and Harvie, R and Martin, A and Jovanovic, L and Hudson, A and Thompson, JF and Nelson, C and Long, A and Steer, C and Harrison, ML and Kannourakis, G and Goldstein, D and Kichenadasse, G and Lowenthal, RM and Stockler, MR and Davis, ID, “Circulating biomarkers and outcomes in a single-arm phase II trial of first-line sunitinib alternating with everolimus for advanced renal cell carcinoma (aRCC): EVERSUN ANZUP trial 0901”, 2014 Genitourinary Cancers Symposium, January, San Francisco, United States (2014) [Conference Extract] |
